Skip to main content
Premium Trial:

Request an Annual Quote

WHO to Set Up Panel to Develop Gene-Editing Standards

The World Health Organization announced it was setting up a team of experts to develop guidelines and standards for gene editing, Reuters reports.

This announcement comes about a week after He Jiankui announced he had used the CRISPR-Cas9 gene-editing tool to modify the CCR5 gene within embryos that were then implanted and brought to term. This revelation was met with widespread criticism, and the International Human Genome Editing Summit, where He then gave a presentation, rebuked him, and said his claim to have gene-edited embryos was "deeply disturbing" and "irresponsible." The organizing committee further said the "the scientific understanding and technical requirements for clinical practice remain too uncertain and the risks too great to permit clinical trials of germline editing at this time."

The WHO says it will work with its member states to put together a working group to study the ethical and safety issues associated with gene editing. "Gene editing may have unintended consequences, this is uncharted water and it has to be taken seriously," Tedros Adhanom Ghebreyesus, the WHO director-general, said during a press briefing, according to Reuters.

"We are talking about human beings, editing should not harm the welfare of the future person," Tedros added. "We have to be very careful, the working group will do that with all openness and transparency."

The Scan

Study Examines Insights Gained by Adjunct Trio RNA Sequencing in Complex Pediatric Disease Cases

Researchers in AJHG explore the diagnostic utility of adding parent-child RNA-seq to genome sequencing in dozens of families with complex, undiagnosed genetic disease.

Clinical Genomic Lab Survey Looks at Workforce Needs

Investigators use a survey approach in Genetics in Medicine Open to assess technologist applications, retention, and workforce gaps at molecular genetics and clinical cytogenetics labs in the US.

Study Considers Gene Regulatory Features Available by Sequence-Based Modeling

Investigators in Genome Biology set sequence-based models against observational and perturbation assay data, finding distal enhancer models lag behind promoter predictions.

Genetic Testing Approach Explores Origins of Blastocyst Aneuploidy

Investigators in AJHG distinguish between aneuploidy events related to meiotic missegregation in haploid cells and those involving post-zygotic mitotic errors and mosaicism.